Author:
Jodrell D.I,Evans T.R.J,Steward W,Cameron D,Prendiville J,Aschele C,Noberasco C,Lind M,Carmichael J,Dobbs N,Camboni G,Gatti B,De Braud F
Reference9 articles.
1. A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumours;Calvert;Clin. Cancer Res.,1999
2. The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent;Gehan;J. Chron Dis.,1961
3. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF);Findlay;Ann. Oncol.,1994
4. Consequences of nucleic acid conformation on the binding of a trinuclear platinum drug;Kloster;Biochemistry,1999
5. A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system;Perego;Mol. Pharmacol.,1999
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献